Michihiro Satoh
Overview
Explore the profile of Michihiro Satoh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
157
Citations
1231
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fujiwara T, Iwashima Y, Narita K, Satoh M, Sakima A
Hypertens Res
. 2025 Mar;
PMID: 40038523
We investigated whether the combination of medical therapy plus percutaneous transluminal renal angioplasty (PTRA) provides superior clinical outcomes compared to those afforded by medical therapy alone in patients with hypertension...
2.
Metoki H, Nobayashi H, Satoh M
Hypertens Res
. 2025 Mar;
PMID: 40033143
Possible diurnal blood pressure variation change due to alcohol consumption. • Normally, blood pressure declines by around 10-20% at night compared to daytime (nocturnal decline, orange line). • In the...
3.
Satoh M, Nobayashi H, Nakayama S, Hirohito M
Hypertens Res
. 2025 Feb;
PMID: 39972182
No abstract available.
4.
Satoh M, Ohkubo T, Miura K, Harada A, Tsutsui A, Hozawa A, et al.
Hypertens Res
. 2025 Feb;
PMID: 39972175
This study examined the association between the latest blood pressure (BP) classification and cardiovascular disease (CVD) mortality risk, using data from 70,570 individuals across 10 Japanese cohorts. Participants were stratified...
5.
Akasaki Y, Suematsu Y, Azushima K, Shiga Y, Sakima A, Satoh M, et al.
Hypertens Res
. 2025 Feb;
PMID: 39962166
Hypertension is a significant risk factor for cardiovascular diseases, with its global prevalence doubling over the past three decades. Despite advancements in antihypertensive therapies, approximately 50% of patients with hypertension...
6.
Satoh M, Nakayama S, Hashimoto H, Toyama M, Iwabe Y, Yagihashi T, et al.
J Clin Lipidol
. 2025 Feb;
PMID: 39934034
Background: We aimed to precisely quantify the risk of coronary heart disease (CHD) among antihypertensive medication users compared to non-users. We similarly assessed the potential CHD risk among lipid-lowering medication...
7.
Nakayama S, Satoh M, Toyama M, Hashimoto H, Murakami T, Hirose T, et al.
Clin Exp Nephrol
. 2025 Jan;
PMID: 39881083
Background: Febuxostat and topiroxostat are non-purine selective xanthine oxidoreductase inhibitors commonly used for hyperuricaemia treatment in Japan. However, comparative data on the effects of febuxostat and topiroxostat on renal function...
8.
Pregnancy and Postpartum Trends in Self-Measured Blood Pressure and Derived Indices: The BOSHI Study
Izumi S, Nishimura M, Iwama N, Tomita H, Hamada H, Obara T, et al.
J Clin Hypertens (Greenwich)
. 2025 Jan;
27(1):e14949.
PMID: 39823166
In this study, we aimed to reveal the trends of self-measured blood pressure (SMBP) and SMBP-derived indices during pregnancy and the postpartum period. The Babies and Their Parents Longitudinal Observation...
9.
Toyama M, Satoh M, Hashimoto H, Iwabe Y, Yagihashi T, Nakayama S, et al.
Hypertens Res
. 2025 Jan;
48(2):786-795.
PMID: 39774308
Previous studies have shown an increase in blood pressure during the coronavirus disease 2019 (COVID-19) pandemic even among patients receiving antihypertensive treatment. This study aims to evaluate the association between...
10.
Maruhashi T, Tatsumi Y, Satoh M, Kobayashi Y, Ogoyama Y, Sakima A, et al.
Hypertens Res
. 2024 Dec;
PMID: 39719531
Home blood pressure (BP) measurement is widely used, and home BP plays a central role in hypertension management in clinical practice in Japan. We updated the systematic review to determine...